Loading...
CRISPR based editing of SIV proviral DNA in ART treated non-human primates
; Chen, Chen ; ; Gordon, Jennifer ; Liao, Shuren ; Robinson, Jake A. ; Smith, Mandy D. ; Liu, Hong ; Sariyer, Rahsan ; Peterson, Tiffany A. ... show 8 more
Chen, Chen
Gordon, Jennifer
Liao, Shuren
Robinson, Jake A.
Smith, Mandy D.
Liu, Hong
Sariyer, Rahsan
Peterson, Tiffany A.
Citations
Altmetric:
Genre
Journal article
Date
2020-11-27
Advisor
Committee member
Department
Neuroscience
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1038/s41467-020-19821-7
Abstract
Elimination of HIV DNA from infected individuals remains a challenge in medicine. Here, we demonstrate that intravenous inoculation of SIV-infected macaques, a well-accepted non-human primate model of HIV infection, with adeno-associated virus 9 (AAV9)-CRISPR/Cas9 gene editing construct designed for eliminating proviral SIV DNA, leads to broad distribution of editing molecules and precise cleavage and removal of fragments of the integrated proviral DNA from the genome of infected blood cells and tissues known to be viral reservoirs including lymph nodes, spleen, bone marrow, and brain among others. Accordingly, AAV9-CRISPR treatment results in a reduction in the percent of proviral DNA in blood and tissues. These proof-of-concept observations offer a promising step toward the elimination of HIV reservoirs in the clinic.
Description
Citation
Mancuso, P., Chen, C., Kaminski, R. et al. CRISPR based editing of SIV proviral DNA in ART treated non-human primates. Nat Commun 11, 6065 (2020). https://doi.org/10.1038/s41467-020-19821-7
Citation to related work
Nature
Featured by Temple Now: https://news.temple.edu/2020-11-28/researchers-make-hiv-breakthrough
Featured by Temple Now: https://news.temple.edu/2020-11-28/researchers-make-hiv-breakthrough
Has part
Nature Communications, Vol. 11, Article number: 6065 (2020)
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
